Gabriella Collu Selected Research

AT-752

10/2021

Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with In Vitro and In Vivo Activity against Dengue and Other Flaviviruses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gabriella Collu Research Topics

Disease

2	Infections 10/2021 - 12/2017
2	Diarrhea 04/2008 - 11/2006
1	Viremia 10/2021
1	Dengue (Dengue Fever) 10/2021
1	COVID-19 01/2021
1	Kidney Neoplasms (Kidney Cancer) 09/2015
1	Poliomyelitis (Polio) 11/2006
1	Neoplasms (Cancer) 03/2006
1	Nasopharyngeal Carcinoma 03/2006

Drug/Important Bio-Agent (IBA)

2	GuanosineIBA 10/2021 - 01/2021
2	ProdrugsIBA 10/2021 - 01/2021
2	NucleotidesIBA 10/2021 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2021 - 11/2006
1	AT-752IBA 10/2021
1	VaccinesIBA 10/2021
1	remdesivirIBA 01/2021
1	AT-511IBA 01/2021
1	Azauridine (6 Azauridine)IBA 12/2017
1	Biological ProductsIBA 09/2015
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 04/2008
1	EnzymesIBA 04/2008
1	NucleosidesIBA 04/2008
1	RNA (Ribonucleic Acid)IBA 11/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2006
1	Etoposide (VP 16)FDA LinkGeneric 03/2006
1	QuinoxalinesIBA 03/2006
1	Vincristine (Oncovin)FDA LinkGeneric 03/2006
1	Pharmaceutical PreparationsIBA 03/2006

Therapy/Procedure

1	Therapeutics 10/2021